Ebv Positive T Cell Lymphoproliferative Disorder Of Childhood C2699838
A rare condition where EBV infection causes abnormal growth of T cells, mainly in children. Requires careful monitoring and treatment with immune-suppressing medications.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Persistent fever
(hematologic)Rash
(hematologic)Hepatosplenomegaly
(hematologic)Hemophagocytic lymphohistiocytosis
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Multi-Agent Chemotherapy Protocol
Intensive chemotherapy regimen combining multiple agents targeting the malignant T-cell population. Protocols typically include agents such as methotrexate, cytarabine, and anthracyclines administered in cycles under oncologist supervision.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Hematopoietic Stem Cell Transplantation
High-dose chemotherapy followed by infusion of donor stem cells to reconstitute the bone marrow and immune system. This potentially curative approach is considered when chemotherapy alone is insufficient or in relapsed disease.
Additional treatment options
Immunotherapy with Interferon-Alpha
Adjunctive immunotherapy using interferon-alpha to enhance immune surveillance against malignant cells and potentially reduce viral burden of EBV. Used in combination with or following primary chemotherapy.
medicationSerial EBV Viral Load Surveillance
Regular PCR-based monitoring of EBV DNA levels in blood to assess disease activity and treatment response. Rising levels may indicate disease progression or recurrence requiring intervention.
monitoringPsychosocial Support and Survivorship Care
Comprehensive psychological support for the child and family throughout treatment and into survivorship, addressing anxiety, depression, and adjustment difficulties. Includes education about the disease and treatment expectations.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Ebv Positive T Cell Lymphoproliferative Disorder Of Childhood C2699838?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Ebv Positive T Cell Lymphoproliferative Disorder Of Childhood C2699838. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy